Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

ADC Therapeutics (ADCT) Cost of Revenue: 2020-2022

Historic Cost of Revenue for ADC Therapeutics (ADCT) over the last 3 years, with Dec 2022 value amounting to $4,579.

  • ADC Therapeutics' Cost of Revenue rose 960.23% to $13.7 million in Q3 2023 from the same period last year, while for Sep 2023 it was $28.8 million, marking a year-over-year increase of 603.45%. This contributed to the annual value of $4,579 for FY2022, which is 228.72% up from last year.
  • Latest data reveals that ADC Therapeutics reported Cost of Revenue of $4,579 as of FY2022, which was up 228.72% from $1,393 recorded in FY2021.
  • In the past 5 years, ADC Therapeutics' Cost of Revenue ranged from a high of $22,101 in FY2020 and a low of $1,393 during FY2021.
  • For the 3-year period, ADC Therapeutics' Cost of Revenue averaged around $9,358, with its median value being $4,579 (2022).
  • As far as peak fluctuations go, ADC Therapeutics' Cost of Revenue crashed by 93.70% in 2021, and later surged by 228.72% in 2022.
  • Yearly analysis of 3 years shows ADC Therapeutics' Cost of Revenue stood at $22,101 in 2020, then slumped by 93.70% to $1,393 in 2021, then skyrocketed by 228.72% to $4,579 in 2022.